Platelet sensitivity in vitro to adenosine-5'-diphosphate and prostacyclin and diabetic retinopathy
- PMID: 3894139
- DOI: 10.1007/BF00271684
Platelet sensitivity in vitro to adenosine-5'-diphosphate and prostacyclin and diabetic retinopathy
Abstract
Platelet sensitivity to adenosine diphosphate and prostacyclin in diabetes has been assessed using collision theory and the concept of 'sticking probability' (the probability of particle union). Twenty Type 1 (insulin-dependent) diabetic men (10 with no or minimal retinopathy and a matched group of 10 with proliferative retinopathy) and 10 age-matched nondiabetic men were studied. Platelets from the 20 diabetic patients required, on average, 37% less adenosine diphosphate to achieve a sticking probability of 0.5 (ED50) compared with platelets from the non-diabetic subjects (medians 1.50 and 0.95 mumol/l, respectively; p less than 0.01). The platelet prostacyclin response was assessed by the dissociation constant (Ki) for inhibition of adenosine diphosphate-induced aggregation. Platelets from the diabetic patients had similar prostacyclin sensitivity to those from the non-diabetic subjects (medians 0.42 and 0.42 respectively). Diabetic patients with and without retinopathy had similar platelet sensitivity to both adenosine diphosphate and prostacyclin.
Similar articles
-
Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic patients.Tohoku J Exp Med. 1982 Aug;137(4):423-8. doi: 10.1620/tjem.137.423. Tohoku J Exp Med. 1982. PMID: 6750843
-
Increased platelet malondialdehyde, but normal platelet sensitivity to adenosine-5-diphosphate and prostacyclin in well-controlled type 1 diabetics without vascular complications.Diabetes Res. 1986 Oct;3(8):401-5. Diabetes Res. 1986. PMID: 3545622
-
Dose-dependent increase in in vitro platelet sensitivity to adenosine-5'-diphosphate in young complication-free diabetic males.Diabetes Res. 1990 Nov;15(3):103-7. Diabetes Res. 1990. PMID: 2132201
-
Vascular prostacyclin, platelet sensitivity to prostaglandins and platelet-specific proteins in diabetes mellitus. Analysis of type of diabetes, state of metabolic control and diabetic microangiopathy.Horm Metab Res Suppl. 1981;11:33-43. Horm Metab Res Suppl. 1981. PMID: 6459282 No abstract available.
-
Biological actions of prostacyclin and its pharmacological use in platelet studies.Adv Exp Med Biol. 1985;192:337-58. doi: 10.1007/978-1-4615-9442-0_24. Adv Exp Med Biol. 1985. PMID: 3010671 Review. No abstract available.
Cited by
-
Thromboxane production and platelet aggregation in type 2 diabetes mellitus without vascular complications.Klin Wochenschr. 1991 Sep 16;69(14):652-6. doi: 10.1007/BF01649426. Klin Wochenschr. 1991. PMID: 1749204
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical